文献速递肺血管病与心包/心肌炎

不同肺动脉高压类型中肺动脉顺应性的比较

Pulmonary artery compliance in different forms of pulmonary hypertension.
PubMed 文献 · Heart · 2023-06-26

该回顾性分析纳入美国肺动脉高压登记研究中2015至2019年的成人PAH患者532例及CTEPH患者84例,比较不同PH亚组间肺动脉顺应性与阻力-顺应时间差异。结果显示各PAH亚组及PAH与CTEPH间PAC无差异;CTEPH的RC时间短于PAH,CTD-PAH的RC时间最短;PAC与无移植生存相关,但校正REVEAL 2.0评分后并非独立预测因子。

要点

  • PAC在各PAH亚组间及PAH与CTEPH间均无差异
  • CTEPH的RC时间短于PAH,CTD-PAH的RC时间在各PAH亚组中最短
  • PAC与无移植生存相关,但校正REVEAL 2.0评分后非独立预测因子

核心结论

  • 不同PH分组间PAC相似,PAC并非PAH无移植生存的独立预测因子。
  • RC时间在不同PH亚组间存在差异,挑战了RC时间为生理常数的观点。

研究设计与样本

  • 回顾性分析美国肺动脉高压协会登记研究中2015至2019年入组的成人PAH患者532例与CTEPH患者84例。
  • 比较CTD-PAH、i/h-PAH、d/t-PAH亚组间PAC与RC时间,并以Cox比例风险模型分析无移植生存,校正REVEAL 2.0风险评分。

主要发现

  • 各PAH亚组间估算PAC无差异,PAH与CTEPH间亦无差异。
  • CTEPH的RC时间短于PAH,中位数0.55(IQR 0.45-0.64)s对0.62(0.52-0.73)s,p<0.0001。
  • CTD-PAH的RC时间短于i/h-PAH与d/t-PAH,(0.59±0.18)对(0.65±0.20)对(0.73±0.25)s,p=0.0001。
  • PAC与无移植生存相关(HR 0.72,95%CI 0.55至0.94,p=0.02),但校正REVEAL 2.0评分后并非独立预测因子。

关键数值与推荐

  • PAC按每搏输出量除以肺动脉脉压估算,RC时间为PAC与肺血管阻力的乘积。
  • CTEPH的RC时间中位数0.55(IQR 0.45-0.64)s,PAH为0.62(0.52-0.73)s,p<0.0001。
  • CTD-PAH、i/h-PAH、d/t-PAH的RC时间分别为(0.59±0.18)、(0.65±0.20)、(0.73±0.25)s,p=0.0001。
  • PAC与无移植生存的HR为0.72(95%CI 0.55至0.94,p=0.02),校正REVEAL 2.0评分后不再独立。

临床怎么用

  • 评估PH患者时不宜假设RC时间恒定,应结合PH亚型解读RC时间。
  • PAC可作为PAH无移植生存的相关指标,但需结合REVEAL 2.0等综合风险评分判断预后。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pulmonary artery compliance (PAC), estimated as stroke volume (SV) divided by pulmonary artery pulse pressure (PP), may be a predictor of survival in pulmonary arterial hypertension (PAH). Resistance-compliance (RC) time, the product of PAC and pulmonary vascular resistance, is reported to be a physiological constant. We investigated if differences in PAC and RC time exist between pulmonary hypertension (PH) subgroups and examined whether PAC is an independent predictor of transplant-free survival in PAH. METHODS: This was a retrospective analysis of adult PAH (n=532) and chronic thromboembolic PH (CTEPH, n=84) patients enrolled in the US Pulmonary Hypertension Association Registry from 2015 to 2019. PAC and RC time were compared between PH subgroups (connective tissue disease-PAH (CTD-PAH), idiopathic/heritable-PAH (i/h-PAH), drug/toxin-PAH (d/t-PAH)). Cox proportional hazards models were constructed for transplant-free survival, adjusting for REVEAL 2.0 risk score. RESULTS: There were no differences in estimated PAC between PAH subgroups, nor between PAH and CTEPH. RC time was shorter in CTEPH compared with PAH (median 0.55 (IQR 0.45-0.64) vs 0.62 (0.52-0.73) s, p<0.0001). RC time was shortest in CTD-PAH when compared with i/h-PAH and d/t-PAH ((0.59±0.18) vs (0.65±0.20) vs (0.73±0.25) s, p=0.0001). PAC was associated with transplant-free survival (HR 0.72, 95% CI 0.55 to 0.94, p=0.02) but was not an independent predictor of outcome after adjustment for REVEAL 2.0 score. CONCLUSION: PAC was similar between PH groups and was not an independent predictor of transplant-free survival in PAH. RC time was different between PH subgroups, challenging RC time constancy. TRIAL REGISTRATION NUMBER: NCT04071327.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. McCormick A, Krishnan A, Badesch D, et al. Pulmonary artery compliance in different forms of pulmonary hypertension. Heart. 2023. PMID: 36787969. doi:10.1136/heartjnl-2022-321760

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。